Not Verified

Joint Call for Proposals with GRI France – “GRI-related disorders”

Foundation for Rare Diseases

Given the unique characteristics of the field of rare diseases, GRI France and the Rare Diseases Foundation have formed a partnership aimed at supporting and advancing research on GRI-related conditions.

Maximum budget: €20,000

Maximum duration: 24 months

Submission deadline: January 7, 2027, 5:00 p.m.(Paris time).

AI Based Application Success Predictor

The Foundation for Rare Diseases (Fondation maladies rares) is a French non-profit organization that funds research into rare diseases, including disease mechanisms, therapeutic development, diagnosis, and quality of life.

Finding cures

Category	Details
Organization type	Non-profit research foundation
Country	France
Primary topic areas	Rare diseases, genetics, molecular biology, translational research, drug discovery, and patient quality of life
Previous success predictors	1. Scientific excellence and originality. 2. Clear relevance to rare diseases. 3. Potential to identify disease mechanisms or improve diagnosis. 4. Therapeutic development potential. 5. Methodological rigor and feasibility. 6. Research team expertise. 7. Access to specialized technologies and research platforms. 8. Collaboration across clinical, scientific, and patient communities. 9. Potential benefits for patients. 10. Alignment with the specific funding call and eligibility requirements. Foundation For Rare Diseases +2
Historical funding data	The foundation reports funding 483 research projects through more than 50 calls, totaling €15.1 million. Foundation For Rare Diseases
Historical success rate	Not verified; total funded projects alone do not reveal the number of applications received.

Excel-ready entry — Previous Success Predictors:

Scientific excellence; research novelty; rare disease relevance; disease mechanism discovery; diagnostic or therapeutic potential; methodological rigor; project feasibility; investigator expertise; access to specialized research technologies; interdisciplinary collaboration; patient impact; and alignment with funding call priorities.

Specialties

Neurosciences

Rare Diseases

Pediatrics

Eligibility Requirements

GRI France and the Rare Diseases Foundation have formed a partnership aimed at supporting and advancing research on GRI-related conditions

Eligible Countries:

France

Sponsor Details

Sponsor Institute/Organizations: Foundation for Rare Diseases

Sponsor Type: Corporate/Non-Profit

Address: 96 rue de Didot, 75014 Paris

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity